Background: With the advent of combined antiretroviral therapy (cART), growing evidence has shown human immunodeficiency virus (HIV) may no longer be an absolute contraindication for solid organ transplantation. This study compares outcomes of heart transplantations between HIV-positive and HIV-negative recipients using SRTR transplant registry data.
| INTRODUC TI ON
Traditionally, transplantation eligibility hinged on a strict set of patient-specific criteria. Patients infected with human immunodeficiency virus (HIV) were generally excluded. [1] [2] [3] However, with the introduction of more effective treatment options for HIV in 1996, such as protease inhibitors and antiretroviral therapy, survival and quality of life have improved markedly in HIV-infected patients. [4] [5] [6] Currently, more than one million Americans are infected with human immunodeficiency virus (HIV). 7 The estimated 10-year survival rate in patients treated with cART exceeds 90% denoting a shift in classifying HIV as a chronic medical condition rather than an acute illness which was life-threatening. 8 Consequently, an increasing number of HIV-positive patients with other co-morbid conditions are presenting with manifestations of end-stage organ dysfunction from chronic HIV infection including chronic liver disease, chronic kidney disease, cardiomyopathy, and end-stage lung disease. [9] [10] [11] Co-infection with hepatitis B/C is common as they share the same routes of infection. Prior to the advent of cART, HIV patients were usually not considered for transplantation because of the poor prognosis of their underlying disease and concerns regarding potential detrimental effects of immunosuppression on viral load and immune status . [1] [2] [3] 12, 13 In this new treatment era, studies supporting renal and hepatic transplantations in HIV-infected patients have shown promising results. 12, [14] [15] [16] South Africa pioneered many successful kidney transplants in HIV-positive patients using HIV-positive donor. 17 Survivors in the study with kidney transplant in HIV-positive patients were followed up for a median of 2.4 years. The rate of patient survival was 84% at year 1% and 74% at year 5. The corresponding graft survival rate, defined as the percentage of functioning graft regardless of patient death, was 93% and 84%. 17 Kidney transplantations hence have been performed successfully in HIV-positive patients; graft and patient survival appear to be similar to that of HIV-negative recipients. 18 In contrast, insufficient data are available for heart transplantation in HIV-positive patients and are limited to a few observational case studies. 19, 20 Even though transplantation may be the last chance of survival for patients with end-stage organ failure, 21 many transplant centers remain reluctant to perform these procedures on HIV-positive patients. 22 Despite recent reports suggesting that patients with HIV do not experience poorer health outcomes when compared to HIV-negative transplant recipients, [23] [24] [25] [26] many transplant centers remain steadfast in the outdated eligibility guidelines.
The case series by Uriel et al reported a 100% survival rate over a 5-year period without development of AIDS-defining illnesses among 7 HIV-positive patients who received heart transplants. 25 However, these case reports are not comprehensive enough to provide conclusive evidence for supporting heart transplantations in HIV-positive patients. Therefore, this study aims to fill this gap by evaluating heart transplant outcomes among HIV-positive and HIV-negative recipients using SRTR transplant registry in the United States.
| ME THODS

| Data source
This study used data from the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all donor, wait-listed candidates, and transplant recipients in the United
States, submitted by the members of the Organ Procurement and Transplantation Network (OPTN), and has been described elsewhere. 27 The 
| Study design
Outcomes in HIV-positive heart transplant recipients were compared to HIV-negative recipients in this retrospective cohort study.
All patients who received a heart transplant over the age of 18 were included. Any patients who received other organ transplants or who did not have a conclusive HIV serology at the time of transplantation were excluded from the study.
Patients were followed from the date of transplantation until the first occurrence of any of the following: end of the fifth transplant year, re-transplantation, death, graft failure of any cause, and loss of follow-up in SRTR data. The end points were defined as patient survival, overall graft survival, and death-censored graft survival. Death with functioning graft was censored in death-censored graft survival analysis, but treated as an event in overall graft survival.
| Statistical analysis
Baseline cohort characteristics were summarized by calculated group median and interquartile for continuous variables and proportional frequencies and percentages for categorical variables. Student t tests and chi-square tests were used to quantify statistically signifi- Transplantation in HIV-positive recipients is relatively infrequent and could impact the validity of traditional multivariate regression with exposure propensity score. [28] [29] [30] With the concern that the exposure is too rare to obtain sufficient power for covariate adjustment, a disease risk score (DRS) method was used to combine covariates into a summary score. This method is better suited for studies with rare exposures and was adopted as an alternative for the adjustment of multiple confounders. 29, 31 This method has been validated by previous simulated and observational studies. 28, 32 To calculate DRS, each study outcome was regressed over the entire cohort on both the exposure variable and covariates. 31 The score was compiled from the fitted values of the model for each study subject when setting the individual exposure variable to unexposed. 31 The quintiles of the DRS were used for covariate adjustment within the final Cox regression model to derive adjusted hazard ratios between HIV-positive and negative patients with better precision. 33 All analyses were performed using SAS software, version 9.4
(SAS Institute Inc, Cary, NC). Statistical significance was based on a P value 0.05, and all confidence intervals used a 95% threshold. 
TA B L E 1 Demographic and clinical characteristics of US heart transplant recipients (HIV-positive vs HIV-negative) from 2004 through 2016
| RE SULTS
Thirty-five HIV-positive heart transplant recipients (HTRs) aged 18 or above were identified using SRTR registry data from 2004 through 2016.
The demographic and clinical characteristics of these 35 HIV-positive cases were summarized in Table 1 Figure 1A ,B,C). None of these differences were statistically significant. This did not change when adjusted for demographic and clinical characteristics using a multivariate Cox regression or DRS adjustment model (Figure 2A ,B,C). Further analyses on other clinical endpoints including biopsy proven rejection, infection, malignancy and renal dysfunction all showed that there were no significant difference between two groups (Table 2 ). coronary arterial disease, myocarditis, cardiomegaly, and malignancy. [37] [38] [39] Similarly, HIV is associated with an increased risk of chronic obstructive pulmonary disease, pulmonary fibrosis, pulmonary arterial hypertension, and lung cancer. [40] [41] [42] It is imperative to develop a clear understanding of the outcomes of heart transplantations in this patient group. Furthermore, HIV infection is no longer considered an absolute contraindication in the updated consensus guidelines developed by the International Society for Heart Lung Transplantation (ISHLT). 43, 44 However, most transplant centers still remain reluctant to perform heart transplantations with this population because of the concerns for increased risk of rejection, infections, HIV reactivation by immunosuppressants, and significant drug-drug interactions. 22 The published literature on this topic is sparse. This study highlights the need to revisit the biases associated with HIV-positive status in heart transplantation.
| DISCUSS IONS
While these findings provide important results derived from the largest known cohort of HIV-positive heart transplantation recipients, the conclusions remain vulnerable to several study limitations. The most prominent of which, is the lack of HIV-positive heart transplant cases observed within the registry. HIV-positive HRTs had relatively short follow-up as more than half these patients had transplant during 2014-2016. Although by using survival analysis we only compared HIV-positive patients with HIV-negative patients who had the same follow-up duration, future research is warranted to examine the long-term outcomes for these patients when more data become available. Besides, this study was only based on the observations included within the registry, hence further studies using other data resources will be needed. 
CO N FLI C T O F I NTE R E S T
None.
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